Naveed Syed Celebrates International Recognition for UAE’s Pediatric Hematology Work
Naveed Syed, Hematology Specialist at Sheikh Shakhbout Medical City, shared a post on LinkedIn:
““If it isn’t documented, it isn’t done.
And now, it’s documented.”
Honoured that our work received 3rd Place at the 4th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress, endorsed by EBMT — a recognition of years of dedication by Abu Dhabi’s pediatric hematology–oncology teams.
Before the UAE had a pediatric transplant center, children needing allogeneic HSCT were fully worked up here, transplanted abroad, and followed up locally — ensuring seamless, coordinated care across borders.
Our analysis — supported by a DOH-funded grant — confirms that survival outcomes for these children matched international standards, despite the absence of a local transplant unit at that time.
This achievement belongs to every hematology oncology physician, nurse, and coordinator who stood by these children and families with unwavering commitment.
From service → to evidence → to impact.”
Stay informed with Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM